cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
YCBD.PRA was delisted on the 5th of May, 2025.
7 hedge funds and large institutions have $131K invested in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
24% less capital invested
Capital invested by funds: $173K → $131K (-$41.8K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
+$3.41K |
| 2 |
CP
Camelot Portfolios
Maumee,
Ohio
|
+$1.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.48K |
| 2 |
MG
Marex Group
London,
|
-$985 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CD
1
Chapin Davis
Baltimore,
Maryland
| $49.6K | – | – | – |
|
|
CL
2
CSS LLC
Chicago,
Illinois
| $46.1K | – | – | – |
|
|
MG
3
Marex Group
London,
| $24.3K | -$985 | -1,446 | -4% |
|
4
Commonwealth Equity Services
Waltham,
Massachusetts
| $6K | – | – | – |
|
|
5
Barclays
London,
United Kingdom
| $3.1K | +$3.41K | +5,000 | New |
|
|
CP
6
Camelot Portfolios
Maumee,
Ohio
| $1.24K | +$1.36K | +2,000 | New |
|
7
Morgan Stanley
New York
| $434 | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$2.48K | -3,000 | Closed |
|
YCBD.PRA Hedge Fund Activity: Q2 2024 in Review
7 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) for Q2 2024, worth a combined $131K — down 24% from $173K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new YCBD.PRA positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Barclays, opening a new position worth an estimated $3.41K. The largest seller was UBS Group, exiting entirely with an estimated $2.48K sold.
- 7 institutional investors held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) as of Q2 2024, up from 6 in Q1 2024.
- Funds reported $131K of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock stock for Q2 2024, down 24% quarter-over-quarter.
- 2 funds opened new cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock positions in Q2 2024 and 1 closed out, a net change of +1 holder.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock buyer in Q2 2024 was Barclays, an estimated $3.41K added.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock seller in Q2 2024 was UBS Group, an estimated $2.48K sold.
Based on aggregated 13F filings for Q2 2024.